2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors Shengxuening Tablet, Ferrous succinate - Hematological Malignancy, Cancer-Related Anemia | Phase 3 | Unknown | Zhongnan Hospital | 168 | 2023-02-07 | 2023-08-25 |
| Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours CAR-T cell therapy - Hematological Malignancy | Phase 2 / Phase 3 | Unknown | Shanxi Bethune Hospital | 30 | 2020-06-15 | 2024-02-02 |
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Site (2)
Immunotherapy, Adoptive (1) · ferrous succinate (1) · shengxuening (1)
Shanxi Bethune Hospital (1) · Zhongnan Hospital (1)
China (2)
Xiaomin Zhang (1)